SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Cadila Healthcare’s Moraiya facility

07 Sep 2017 Evaluate

Cadila Healthcare’s Moraiya facility was successfully inspected by the US Food and Drug Administration (USFDA) and there were no observations (483) during the inspection. The inspection was carried out between August 31, 2017 to September 7, 2017.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.


Zydus Lifesciences Share Price

941.15 -1.40 (-0.15%)
20-Apr-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.00
Dr. Reddys Lab 1237.40
Cipla 1237.70
Zydus Lifesciences 941.15
Lupin 2333.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×